Healthy men needed for first human test of new acromegaly drug
Knowledge-focused
Recruiting now
This early-stage study tests whether MAR002 is safe and tolerable in healthy men. It is the first time this drug is given to humans. The study involves 45 healthy men aged 18-40 who will receive either MAR002 or a placebo. The goal is to check for side effects and how the drug mo…
Phase: PHASE1 • Sponsor: Marea Therapeutics • Aim: Knowledge-focused
Last updated May 05, 2026 11:55 UTC